VeriMomdihydroquercetin hamilelikte güvenli mi?
No harmonised CLP reproductive classifications (no H360/H361) and no CIR or SCCS safety assessment indicating reproductive hazard. Peer‑reviewed literature on taxifolin (dihydroquercetin) reports antioxidant and pharmacologic effects but does not provide evidence of teratogenicity or reproductive toxicity in humans; ECHA entries are registrations/self‑notifications without harmonised reproductive classification. Dermal exposure from cosmetics is expected to be low but measurable based on compound physicochemistry and cosmetic use patterns (PubChem; ECHA registration dossiers; PubMed).
Pregnancy-safe products containing dihydroquercetin
Related ingredients
Frequently asked questions
- dihydroquercetin hamilelikte güvenli mi?
- No harmonised CLP reproductive classifications (no H360/H361) and no CIR or SCCS safety assessment indicating reproductive hazard. Peer‑reviewed literature on taxifolin (dihydroquercetin) reports antioxidant and pharmacologic effects but does not provide evidence of teratogenicity or reproductive toxicity in humans; ECHA entries are registrations/self‑notifications without harmonised reproductive classification. Dermal exposure from cosmetics is expected to be low but measurable based on compound physicochemistry and cosmetic use patterns (PubChem; ECHA registration dossiers; PubMed).
- dihydroquercetin emzirirken güvenli mi?
- No evidence of reproductive or lactation toxicity or of mechanisms that would specifically target lactation transfer. No harmonised classifications or regulatory warnings for breastfeeding. Systemic exposure from topical use is expected to be low but measurable; transfer into breast milk is not documented in the literature.
- dihydroquercetin bebek cildi için güvenli mi?
- No infant‑specific reproductive or developmental toxicity data identified. Hazard and mechanistic evidence for developmental effects are absent. Exposure score increased for baby skin because infant/young child skin has higher surface‑area‑to‑weight and a less mature barrier, so low/measurable adult dermal absorption is plausibly higher in infants (PubChem; ECHA registration dossiers; PubMed).
- VeriMom dihydroquercetin nasıl puanlıyor?
- VeriMom dihydroquercetin'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 93/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte dihydroquercetin yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.